Construction and validation of a nomogram for hepatocellular carcinoma patients treated by traditional Chinese medicine based on inflammation, nutrition, and blood lipid indicators

被引:3
|
作者
Yu, Xiaopeng [1 ]
Yang, Renyi [1 ]
He, Zuomei [2 ,3 ]
Zeng, Puhua [2 ,3 ]
机构
[1] Hunan Univ Chinese Med, Changsha 410208, Hunan, Peoples R China
[2] Affiliated Hosp, Hunan Acad & Tradit Chinese Med, Changsha 410006, Hunan, Peoples R China
[3] Hunan Acad Tradit Chinese Med, Canc Res Inst, Changsha 410006, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatocellular carcinoma; Nomogram; Survival prognosis; Traditional Chinese medicine; PRETREATMENT ALBUMIN/GLOBULIN RATIO; TO-LYMPHOCYTE RATIO; RECURRENCE; PREDICTOR; SURVIVAL; OUTCOMES; ALBUMIN;
D O I
10.1007/s00432-023-04830-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeTo establish a nomogram for hepatocellular carcinoma (HCC) patients treated by traditional Chinese medicine (TCM).MethodsClinical cases of HCC patients treated by TCM at Hunan Integrated Traditional Chinese and Western Medicine Hospital, and it was randomly divided into the training cohort (n = 222) and the validation cohort (n = 95). In the training cohort, independent risk factors were determined by Cox regression analysis and a nomogram was constructed. The efficiency and clinical applicability of nomograms were evaluated using time-dependent curves, calibration, and the decision curve (DCA), and the patients were divided into high-risk, middle-risk and low-risk groups using X-tile software.ResultsMultivariate Cox regression analysis screened 6 independent risk factors to construct a nomogram of HCC patients, including TNM stage, treatment methods, high-density lipoprotein (HDL), neutrophil-to-lymphocyte ratio (NLR), albumin-to-globulin ratio (AGR), and prognostic nutritional index (PNI). The consistency index (C-index) of the nomogram of the training was 0.811 (0.794-0.829) and the validation cohort was 0.825 (0.800-0.849). The time dependency showed the AUC values of the nomogram for 3 and 5 years in training cohort were 0.894 (95% CI 0.840-0.948) and 0.952 (95% CI 0.914-0.990), and the validation cohort were 0.928 (95% CI 0.865-0.990) and 0.96 3(95% CI 0.916-1.010). The calibration plot showed the nomogram fits well onto perfect curves, and the DCA curve showed the net benefit of the nomogram at a certain probability threshold is significantly higher than the net benefit of the TNM stage at the same threshold probability. Finally, all the patients were divided into high-risk, middle-risk and low-risk groups based on the total score of nomogram, and it showed effectively how to identify to high-risk patients.ConclusionThe nomogram established by the independent risk factors of TNM stage, treatment methods, HDL, AGR, NLR and PNI can predict the prognosis of HCC patients treated by TCM, providing an effective tool to clinical workers to evaluate the prognosis and survival time of HCC patients.
引用
收藏
页码:8969 / 8979
页数:11
相关论文
共 50 条
  • [1] Construction and validation of a nomogram for hepatocellular carcinoma patients treated by traditional Chinese medicine based on inflammation, nutrition, and blood lipid indicators
    Xiaopeng Yu
    Renyi Yang
    Zuomei He
    Puhua Zeng
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 8969 - 8979
  • [2] Construction and validation of a nomogram for hepatocellular carcinoma patients based on HCC-GRIm score
    Xiaopeng Yu
    Renyi Yang
    Zuomei He
    Kexiong Li
    Puhua Zeng
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 12013 - 12024
  • [3] Construction and validation of a nomogram for hepatocellular carcinoma patients based on HCC-GRIm score
    Yu, Xiaopeng
    Yang, Renyi
    He, Zuomei
    Li, Kexiong
    Zeng, Puhua
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (13) : 12013 - 12024
  • [4] Construction and validation of a nomogram for patients with multiple hepatocellular carcinoma: A SEER-based study
    Shen, Jie
    Zhou, Yu
    Yu, Bin
    Zhao, Kailiang
    Ding, Youming
    EJSO, 2023, 49 (10):
  • [5] Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma
    Xi, Sheng-Yan
    Minuk, Gerald Yosel
    WORLD JOURNAL OF HEPATOLOGY, 2018, 10 (11) : 799 - 806
  • [6] Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma
    Sheng-Yan Xi
    Gerald Yosel Minuk
    World Journal of Hepatology, 2018, (11) : 799 - 806
  • [7] Construction and validation of a nomogram for predicting cancer-specific survival in hepatocellular carcinoma patients
    Kang Liu
    Gaobo Huang
    Pengkang Chang
    Wei Zhang
    Tao Li
    Zhijun Dai
    Yi Lv
    Scientific Reports, 10
  • [8] Construction and validation of a nomogram for predicting cancer-specific survival in hepatocellular carcinoma patients
    Liu, Kang
    Huang, Gaobo
    Chang, Pengkang
    Zhang, Wei
    Li, Tao
    Dai, Zhijun
    Lv, Yi
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [9] Construction and validation of a SEER-based prognostic nomogram for young and middle-aged males patients with hepatocellular carcinoma
    Yang, Renyi
    Yu, Xiaopeng
    Zeng, Puhua
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10099 - 10108
  • [10] Construction and validation of a SEER-based prognostic nomogram for young and middle-aged males patients with hepatocellular carcinoma
    Renyi Yang
    Xiaopeng Yu
    Puhua Zeng
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 10099 - 10108